Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios are Not Different among Breast Cancer Subtypes
Open Access
- 1 August 2017
- journal article
- Vol. 18 (8) , 2227-2231
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant settingTumor Biology, 2014
- Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?International Journal of Clinical Oncology, 2014
- Breast tumor subgroups reveal diverse clinical prognostic powerScientific Reports, 2014
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- Tumor associated macrophages and neutrophils in cancerImmunobiology, 2013
- Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysisInternational Journal of Cancer, 2013
- Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patientsMedical Oncology, 2013
- Usefulness of Pretreatment Neutrophil to Lymphocyte Ratio in Predicting Disease-Specific Survival in Breast Cancer PatientsJournal of Breast Cancer, 2013
- Cancer-related inflammation: Common themes and therapeutic opportunitiesSeminars in Cancer Biology, 2012
- Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03European Journal of Cancer, 2009